文献速递腹部介入USCT

超声造影在肝细胞癌经导管动脉化疗栓塞术后早期疗效评估中的价值

Utility of Contrast-Enhanced Ultrasound for Early Therapeutic Evaluation of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization.
PubMed 文献 · J Ultrasound Med · 2019-08-22

本研究回顾性纳入2014年4月至2016年6月间经导管动脉化疗栓塞(TACE)后即刻非增强CT证实碘油均匀沉积的89个肝细胞癌(HCC)病灶,比较TACE后1-2天超声造影(CEUS)与约4周后增强CT(CECT)评估治疗反应的诊断准确率。两种方法的准确率均为83.1%(95%CI 73.7%-90.2%),差值0%低于预设非劣效界值15%,CEUS非劣效于CECT。作者认为CEUS可用于TACE后早期疗效评估,以便在术后数天内制定下一步治疗策略。

要点

  • TACE后1-2天CEUS评估HCC治疗反应的准确率为83.1%(95%CI 73.7%-90.2%)。
  • TACE后约4周CECT评估的准确率同为83.1%(95%CI 73.7%-90.2%),两者差值0%。
  • CEUS在TACE后早期评估中非劣效于约4周后的CECT(非劣效界值15%)。

核心结论

  • CEUS对TACE后HCC早期疗效评估有用,可在TACE后数天内规划下一步治疗策略。

研究设计与样本

  • 回顾性研究,纳入2014年4月至2016年6月间TACE后即刻非增强CT证实碘油均匀沉积的HCC病灶89个。
  • 以TACE后约4周CECT为对照,评估TACE后1-2天CEUS诊断治疗反应的非劣效性,预设非劣效界值为15%。

关键影像表现/征象

  • CEUS于TACE后1-2天评估治疗反应,CECT于TACE后约4周评估。
  • 89个病灶中完全缓解57个(64.0%),不完全缓解32个(36.0%)。

诊断标准与关键数值

  • CEUS(TACE后1-2天)评估治疗反应的准确率为83.1%(95%CI 73.7%-90.2%)。
  • CECT(TACE后约4周)评估治疗反应的准确率为83.1%(95%CI 73.7%-90.2%)。
  • 两种方法诊断准确率差值为0%,低于预设非劣效界值15%,CEUS非劣效于CECT。

临床应用与阅片要点

  • 作者认为CEUS是TACE后HCC早期疗效评估的有用方法,可在TACE后数天内规划下一步治疗策略。
  • 本研究选择TACE后即刻非增强CT证实碘油均匀沉积的HCC病灶进行CEUS评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We aimed to investigate whether contrast-enhanced ultrasound (CEUS) could be useful for early evaluation of the treatment response to transcatheter arterial chemoembolization (TACE) of hepatocellular carcinoma (HCC).

METHODS: This study retrospectively selected HCCs in which homogeneous retention of iodized oil was confirmed on non-contrast-enhanced computed tomography performed immediately after TACE. Therapeutic responses of HCCs were evaluated by CEUS 1 to 2 days after TACE and by contrast-enhanced computed tomography (CECT) approximately 4 weeks after TACE. We investigated the noninferiority of CEUS 1 to 2 days after TACE to CECT approximately 4 weeks after TACE in terms of the diagnostic accuracy of the therapeutic response to TACE on HCC.

RESULTS: Eighty-nine HCCs were enrolled in this study between April 2014 and June 2016. A complete response was observed in 57 of 89 nodules (64.0%), and an incomplete response was observed in the remaining 32 nodules (36.0%). The accuracy rates for CEUS 1 to 2 days after TACE and CECT approximately 4 weeks after TACE in the therapeutic effect of TACE on HCCs were 83.1% (95% confidence interval, 73.7%-90.2%) and 83.1% (95% confidence interval, 73.7%-90.2%), respectively. The difference in diagnostic accuracy between methods was 0%, which was below the predetermined noninferiority limit of 15%, and CEUS 1 to 2 days after TACE was noninferior to CECT approximately 4 weeks after TACE.

CONCLUSIONS: Our results suggest that CEUS is a useful modality for early therapeutic evaluation of TACE for HCC, and we can thus plan the next treatment strategies for HCC within a few days after TACE.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Watanabe Y, Ogawa M, Kumagawa M, et al. Utility of Contrast-Enhanced Ultrasound for Early Therapeutic Evaluation of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization. J Ultrasound Med. 2019. PMID: 31436341. doi:10.1002/jum.15118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。